13 completed. 13 Phase 2, 5 Phase 3, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 13 | Completed 13 |
| Phase 3 | 5 | Completed 5 |
| Phase 1 | 1 | Completed 1 |
Follow Tennis Elbow: new trials by email Literature Review of Tennis Elbow trials Research Report on Tennis Elbow
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of TenoMiR in Lateral Epicondylitis TenoMiR, 0.9% Sodium Chloride Injection - Tennis Elbow | Phase 2 | Completed | Causeway Therapeutics | 123 | 2024-04-10 | 2025-08-01 |
| Treatment of Intractable Common Extensor Tendon Injury Using Mesenchymal Stem Cells (Allo-ASC) High concentration of Allo-ASC, Low concentration of Allo-ASC, Fibrin glue - Lateral Epicondylitis | Phase 2 | Completed | Seoul National University Hospital | 30 | 2018-03-15 | 2025-04-06 |
| An Investigation of Tendoncel, a Novel Topical Platelet Lysate Gel, in the Treatment of Lateral Epicondylitis Tendoncel, Placebo control gel - Lateral Epicondylitis | Phase 2 | Completed | Cell Therapy Ltd. | 30 | 2014-05-01 | 2019-12-12 |
| Safety and Efficacy Study of Allogeneic Adipose-derived Stem Cells for Treatment of Lateral Epicondylitis ALLO-ASC-TI, Placebo - Tennis Elbow | Phase 1 / Phase 2 | Completed | Anterogen Co., Ltd. | 30 | 2014-01-01 | 2016-11-23 |
| Effectiveness of Steroid Injection in Treating Patients With Lateral Epicondylitis Depomedrol, Placebo - Lateral Epicondylitis | Phase 2 / Phase 3 | Completed | Isfahan University of Medical Sciences | 78 | 2013-05-01 | 2013-11-18 |
| Phase II Study of the Effects of rhPDGF-BB Injection on Lateral Epicondylitis rhPDGF-BB Injection, Placebo - Lateral Epicondylitis | Phase 2 | Completed | BioMimetic Therapeutics | 100 | 2012-12-12 | 2019-07-02 |
| Efficacy of Injection Therapy for Lateral Epicondylosis Dextrose prolotherapy, PrT-DMS, Platelet Rich Plasma injection - Tennis Elbow | Phase 2 | Completed | University of Wisconsin, Madison | 31 | 2009-06-01 | 2019-02-18 |
| Influence of Microcurrent Parameters on Effectiveness in Treatment of Chronic Tennis Elbow Microcurrent treatment (controlled current), Micocurrent treatment (controlled voltage) - Tennis Elbow | Phase 2 / Phase 3 | Completed | University of Hertfordshire | 24 | 2009-04-01 | 2010-06-22 |
| Effectiveness of Microcurrent for Treatment of Tennis Elbow Microcurrent (Elexoma Medic) - Tennis Elbow | Phase 2 / Phase 3 | Completed | University of Hertfordshire | 24 | 2008-12-01 | 2010-06-22 |
| Dexamethasone Iontophoretic Patch for the Treatment of Pain Associated With Lateral Epicondylitis Dexamethasone Iontophoretic Patch (low dose), Dexamethasone Iontophoretic Patch (high dose), Dexamethasone Passive Patch - Lateral Epicondylitis, (Tennis Elbow) | Phase 2 | Completed | Travanti Pharma Inc. | 216 | 2008-10-01 | 2015-05-13 |
| Prolotherapy for the Treatment of Chronic Lateral Epicondylitis Prolotherapy, Placebo - Lateral Epicondylitis, Tennis Elbow | Phase 2 / Phase 3 | Completed | University of Pittsburgh | 67 | 2007-09-01 | 2016-05-16 |
| A Randomized Control Trial to Evaluate the Efficacy of Autologous Blood Injection Versus Local Corticosteroid Injection for Treatment of Lateral Epicondylitis Autologous blood injection, Local corticosteroid injection - Tennis Elbow, Epicondylitis, Lateral Humeral | Phase 2 / Phase 3 | Completed | Dojode, Chetan M., MBBS, MS | 60 | 2007-01-01 | 2010-07-28 |
| ALGRX 4975 in the Treatment of Tennis Elbow ALGRX 4975 - Tennis Elbow | Phase 2 | Completed | AlgoRx Pharmaceuticals | 45 | 2004-11-01 | 2006-12-20 |
Arm Injuries (13) · Elbow Injuries (13) · Elbow Tendinopathy (13) · Muscular Diseases (13) · Musculoskeletal Diseases (13) · Tendinopathy (13) · Tendon Injuries (13) · Wounds and Injuries (13)
Saline Solution (2) · Sodium Chloride (2) · Becaplermin (1) · Fibrin Tissue Adhesive (1) · Glucose (1) · Prolotherapy (1)
University of Hertfordshire (2) · AlgoRx Pharmaceuticals (1) · Anterogen Co., Ltd. (1) · BioMimetic Therapeutics (1) · Causeway Therapeutics (1) · Cell Therapy Ltd. (1) · Dojode, Chetan M., MBBS, MS (1) · Isfahan University of Medical Sciences (1) · Seoul National University Hospital (1) · Travanti Pharma Inc. (1) · University of Pittsburgh (1) · University of Wisconsin, Madison (1)
United States (5) · United Kingdom (3) · South Korea (2) · Greece (1) · India (1) · Iran (1) · Slovakia (1)
David P Rabago, MD (1) · Dr. Chetan M Dojode, MBBS,MS(Ortho) (1) · Edward Akelman, MD (1) · Gabriel Vasko, MD PhD (1) · Givissis Panagiotis, MD (1) · John Wilson, MD (1) · Mohamad A Tahririan, MD (1) · Robert Arnold (1) · Ronald M Glick, MD (1) · S G Chung, M.D., Ph.D (1) · Sun Gun Chung, MD, PhD (1)
R21AT003969 (1)